Silk Road Medical
Silk Road Medical is the official engineer of the TCAR Procedure and offers a range of products designed for transcarotid access and neuroprotection during carotid interventions.
Company Overview
Silk Road Medical is the official engineer of the TCAR Procedure, a minimally invasive approach to carotid intervention that combines the neuroprotection of surgery with the advantages of a less invasive procedure. The company is headquartered at 1213 Innsbruck Dr., Sunnyvale, CA 94089.
TCAR Procedure
Silk Road Medical's TCAR (TransCarotid Artery Revascularization) procedure is designed to provide best-in-class stroke protection while minimizing adverse events. The procedure has a published procedural stroke rate of 0.6%, the lowest reported stroke rate of any carotid intervention. The TCAR procedure offers patients and hospitals additional benefits, such as reduced invasiveness and enhanced safety.
Products
Silk Road Medical offers a dedicated line of TCAR products aimed at delivering protection from stroke. These include the ENROUTE® Transcarotid Neuroprotection System, ENROUTE® Transcarotid Stent System, ENROUTE Enflate® Transcarotid RX Balloon Dilatation Catheter, ENHANCE® Transcarotid Peripheral Access Kit, and ENROUTE® 0.014” Guidewire. Each product is specifically designed for transcarotid access and carotid artery angioplasty and stenting procedures.
ENROUTE® Transcarotid Neuroprotection System
The ENROUTE® Transcarotid Neuroprotection System by Silk Road Medical allows for the reversal of blood flow away from the brain to ensure complete neuroprotection during carotid intervention. This system is intended for transcarotid vascular access, introduction of diagnostic agents and therapeutic devices, and embolic protection during carotid artery angioplasty and stenting procedures.
Clinical Results and Evidence
Silk Road Medical places a strong focus on clinical results and evidence, with multiple studies supporting the efficacy of their TCAR procedure. The robust clinical data demonstrate the procedure's effectiveness in providing stroke protection, evidenced by the lowest reported procedural stroke rate of any carotid intervention.